179 related articles for article (PubMed ID: 18306037)
1. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil, an inhibitor of phosphodiesterase subtype 5, prevents indomethacin-induced small-intestinal ulceration in rats via a NO/cGMP-dependent mechanism.
Kato N; Mashita Y; Kato S; Mitsufuji S; Yoshikawa T; Takeuchi K
Dig Dis Sci; 2009 Nov; 54(11):2346-56. PubMed ID: 19101800
[TBL] [Abstract][Full Text] [Related]
3. Prevention by lansoprazole, a proton pump inhibitor, of indomethacin -induced small intestinal ulceration in rats through induction of heme oxygenase-1.
Yoda Y; Amagase K; Kato S; Tokioka S; Murano M; Kakimoto K; Nishio H; Umegaki E; Takeuchi K; Higuchi K
J Physiol Pharmacol; 2010 Jun; 61(3):287-94. PubMed ID: 20610858
[TBL] [Abstract][Full Text] [Related]
4. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
[TBL] [Abstract][Full Text] [Related]
5. 16,16-Dimethyl prostaglandin E2 inhibits indomethacin-induced small intestinal lesions through EP3 and EP4 receptors.
Kunikata T; Tanaka A; Miyazawa T; Kato S; Takeuchi K
Dig Dis Sci; 2002 Apr; 47(4):894-904. PubMed ID: 11991626
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats.
Mizoguchi H; Ogawa Y; Kanatsu K; Tanaka A; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2001 Oct; 16(10):1112-9. PubMed ID: 11686837
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of pranlukast, a cysteinyl-leukotriene receptor 1 antagonist, on indomethacin-induced small intestinal damage in rats.
Nishio H; Hayashi Y; Terashima S; Takeuchi K
Inflammopharmacology; 2007 Dec; 15(6):266-72. PubMed ID: 18236018
[TBL] [Abstract][Full Text] [Related]
8. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
9. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of thiaton, an antispasmodic drug, against indomethacin-induced intestinal damage in rats.
Kunikata T; Miyazawa T; Kanatsu K; Kato S; Takeuchi K
Jpn J Pharmacol; 2002 Jan; 88(1):45-54. PubMed ID: 11855677
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
12. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats.
Zhang X; Tajima K; Kageyama K; Kyoi T
World J Gastroenterol; 2008 Aug; 14(30):4784-90. PubMed ID: 18720540
[TBL] [Abstract][Full Text] [Related]
13. Roles of enterobacteria, nitric oxide and neutrophil in pathogenesis of indomethacin-induced small intestinal lesions in rats.
Konaka A; Kato S; Tanaka A; Kunikata T; Korolkiewicz R; Takeuchi K
Pharmacol Res; 1999 Dec; 40(6):517-24. PubMed ID: 10660951
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats.
Amagase K; Ochi A; Sugihara T; Kato S; Takeuchi K
J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S111-8. PubMed ID: 20586851
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons.
Kato S; Tanaka A; Kunikata T; Umeda M; Takeuchi K
Digestion; 2000; 61(1):39-46. PubMed ID: 10671773
[TBL] [Abstract][Full Text] [Related]
16. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
17. Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Kubo Y; Kumano A; Kamei K; Amagase K; Abe N; Takeuchi K
Dig Dis Sci; 2010 Jun; 55(6):1570-80. PubMed ID: 19707872
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus (FK506), an immunosuppressive agent, prevents indomethacin-induced small intestinal ulceration in the rat: inhibition of inducible nitric oxide synthase expression.
Kato S; Nishio H; Ogura M; Takeuchi K
J Pharmacol Sci; 2007 Jan; 103(1):40-7. PubMed ID: 17202747
[TBL] [Abstract][Full Text] [Related]
19. Lubiprostone prevents nonsteroidal anti-inflammatory drug-induced small intestinal damage by suppressing the expression of inflammatory mediators via EP4 receptors.
Hayashi S; Kurata N; Yamaguchi A; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Jun; 349(3):470-9. PubMed ID: 24713141
[TBL] [Abstract][Full Text] [Related]
20. Influence of Adrenalectomy on Protective Effects of Urocortin I, a Corticotropin-Releasing Factor, Against Indomethacin-Induced Enteropathy in Rats.
Takeuchi K; Abe N; Kumano A
Curr Neuropharmacol; 2016; 14(8):866-875. PubMed ID: 27397599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
